Skip to main content

Implementing Outpatient Therapies to Prevent Progression to Severe COVID-19

This item is expired.

Despite the availability of vaccines, SARS-CoV-2 has continued to circulate, reflecting vaccine hesitancy, misinformation, opposition to masking, and new strains of SARS-CoV-2 (e.g., Delta, Omicron, etc.). With the availability of outpatient treatments, primary care clinicians are positioned to prevent the progression of mild and moderate COVID-19 to severe disease and improve outcomes. This activity will examine the clinical data on the outpatient COVID-19 therapies and provides a framework for identifying eligible patients and designing treatment strategies. Case scenarios are included for clinicians to apply data to patients encountered in clinical practice.

Learning Objectives

  • Describe guideline‐based recommendations for COVID‐19 testing
  • Quickly and confidently make a COVID‐19 diagnosis based on test results
  • Competently assess treatments and select the treatment option for each patient according to guidelines and recommendations
  • Evaluate data surrounding borderline or clinically difficult COVID‐19 cases
  • Improve physician performance in testing, diagnosis, counseling, and treatment in a clinical setting.


Lokesh Goyal, DO
CHRISTUS Spohn Hospital Corpus Christi - Shoreline, Sound Physicians, Hospitalist

Conflict of Interest Disclosures
ACOFP requires any person who could impact the content of this activity to disclose all financial relationships with ineligible companies. ACOFP then identifies any relevant financial relationships and mitigates risk of bias using a series of strategies for relevant relationships.

None of the individuals in control of the content of this activity have any relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Dr. Goyal, faculty for this activity, has no relevant relationships with ineligible companies to disclose.

Requirements for Successful Completion
To successfully complete this activity, participants must:
  • Read the text-based content
  • Pass the post-test (70% or greater)
  • Complete the activity evaluation
  • Claim credit
A certificate will be immediately available.

Commercial Support
This activity is commercially supported by an educational grant from Pfizer.

Accreditation and Credit Statements
The American College of Osteopathic Family Physicians (ACOFP) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.

ACOFP designates this program for a maximum number of .75 AOA Category 1-B credit and will report CME with the extent of the physician’s participation in this activity.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of ACOFP and American College of Osteopathic Obstetricians and Gynecologists (ACOOG). ACOFP is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for physicians.

ACOFP designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

This program is sponsored by ACOFP for educational purposes only. The material presented is not intended to represent the sole or best medical interventions for the discussed diagnoses, but rather is intended to present the opinions of the authors or presenters that may be helpful to other practitioners. Attendees participating in this medical education program do so with the full knowledge that they waive any claim they may have against ACOFP for reliance on any information presented during these educational activities.